NCT00902603View on ClinicalTrials.gov

Ventavis® Registry Protocol

TerminatedOBSERVATIONAL
Enrollment

148

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Commercial Ventavis® (iloprost)

Commercial Ventavis® (iloprost) administered via portable nebulizer (I-neb® AAD® system using the power disc-6)

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY